Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls
NCT ID: NCT03679858
Last Updated: 2018-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-01-01
2019-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter
NCT02906878
A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban
NCT02207725
A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)
NCT06575517
Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization
NCT02433587
Reversal of the Antithrombotic Action of New Oral Anticoagulants
NCT01478282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platelet function test in patients
Platelet function test in patients on antiplatelet therapy
Platelet function test
Ex vivo platelet aggregation analysis by Multiplate aggregometer
Platelet function test in healthy
Platelet function test in healthy subjects
Platelet function test
Ex vivo platelet aggregation analysis by Multiplate aggregometer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet function test
Ex vivo platelet aggregation analysis by Multiplate aggregometer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pecs
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tihamér Molnár
associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tihamer Molnar, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pécs Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pécs
Pécs, Baranya, Hungary
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
description about Multiple Electrode Aggregometry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTE6735
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.